Table 2 ; factors associated with stunting at bivariate and multivariate analysis
Variable | No stunting 79 (84%) | Stunting 15 (16%) | Odds Ratio (95% CI) | P-value | Adjusted Odds Ratio (95% CI | P-value |
|---|---|---|---|---|---|---|
Age of the child | ||||||
Under 5 years | 13(16.4) | 3(20.0) | 1.00 | |||
Above 5 years | 66(83.5) | 12(80.0) | 1.27(0.31,5.14) | 0.738 | ||
Sex | ||||||
Female | 40(50.6) | 6(40.0) | 1.00 | |||
Male | 39(49.4) | 9(60.0) | 1.54(0.50,4.73) | 0.452 | ||
Education level of care giver | ||||||
Primary and below* | 40(50.6) | 9(60.0) | 1.46(0.47,4.49) | 0.507 | ||
Secondary and above | 39(49.4) | 6(40.0) | 1.00 | |||
Distance to the health facility | ||||||
< 5 km | 9(11.4) | 1(6.7) | 1.00 | |||
≥ 5 km | 70(88.6) | 14(93.3) | 1.80(0.21,15.36) | 0.591 | ||
Relapses | ||||||
No | 43(54.4) | 9 (60.0) | 1.00 | |||
Yes | 36(45.6) | 6(40.0) | 0.79(0.25,2.45) | 0.691 | ||
Steroid resistant nephrotic syndrome | ||||||
No | 65(82.3) | 8(53.3) | 1.00 | 1.00 | ||
Yes | 14(17.7) | 7(46.7) | 4.06 (1.26,13.05) | 0.019 | 1.53(0.25,9.39) | 0.648 |
Steroid dependent nephrotic syndrome | ||||||
No | 47(59.5) | 9(60.0) | 1.00 | |||
Yes | 32(40.5) | 6(40.0) | 0.97(0.32,3.02) | 0.971 | ||
Estimated GFR | ||||||
≥ 60 ml/min/1.73m2 | 69(88.5) | 9(60.0) | 1.00 | 1.00 | ||
< 60 ml/min/1.73m2 | 9(11.5) | 6(40.0) | 5.11(1.47,17.75) | 0.010 | 2.05(0.44,9.43) | 0.358 |
Dietary diversity score | ||||||
≥ 4 food groups | 5(6.3) | 1(6.7) | 1.00 | |||
< 4 food groups | 74(93.7) | 14(93.3) | 0.95(0.10.8.72) | 0.961 | ||
Oedema | ||||||
No | 71(89.9) | 10(66.7) | 1.00 | 1.00 | ||
Yes | 8(10.1) | 5(33.3) | 4.44(1.12,16.26) | 0.025 | 3.48(0.81,14.99) | 0.091 |
Tacrolimus | ||||||
No | 71(89.9) | 10(66.7) | 1.00 | 1.00 | ||
Yes | 8(10.1) | 5(33.3) | 4.44(1.21,16.26) | 0.025 | 1.34(0.19,9.67) | 0.769 |
Urine protein | ||||||
Nil | 61(77.2) | 5(33.3) | 100 | 1.00 | ||
Present | 18(22.8) | 10(66.7) | 6.78 (2.05,22.39) | 0.002 | 4.11(1.05,15.98) | 0.041 |
Steroid therapy duration | 19.8(14.5–21.1) | 14.7(3.7–25.6) | 0.98(0.96,1.02) | 0.422 | ||
Cumulative dose | 400.1(255.5-544.6) | 266.5(107.9-425.1) | 0.99(0.99,1.01) | 0.427 |